ArticleInternational journal of molecular sciences2024

Combination Therapy with a TLR7 Agonist and a BRD4 Inhibitor Suppresses Tumor Growth via Enhanced Immunomodulation.

Yong-Si Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.